Predictive Oncology将融资3.444亿美元以启动ATH代币金库策略

Blockbeats
Sep 29

BlockBeats 消息,9 月 29 日,医疗设备公司 Predictive Oncology Inc.(纳斯达克代码:POAI)今日宣布已确定两笔私募融资交易的定价,以支持其数字资产库策略的实施,其中核心持有资产将是 Aethir 生态系统的原生功能型代币 ATH。公司将通过两笔上市公司私募投资(PIPE)融资合计约 3.444 亿美元,用于普通股和预先认股权证的购买和出售:现金 PIPE:公司将发行约 6,670 万股普通股(或以预先认股权证替代普通股)每股发行价为 0.7751 美元,总现金毛收益约为 5,170 万美元。加密 PIPE:公司将发行最多 2.236 亿份预先认股权证,每份价格为发行价减去 0.01 美元,以换取约 2.927 亿美元的名义价值,折算约 1.733 亿美元的折扣价值,形式为锁仓和非锁仓 Aethir 代币的实物出资。加密 PIPE 中的预先认股权证将在公司获得股东批准后立即可行权。两笔 PIPE 预计将于 2025 年 10 月 2 日左右同时完成交割,前提是满足常规交割条件。公司计划将 Aethir (ATH) 的实物出资用于实施数字资产库策略,并利用 PIPE 的剩余净收益主要在公开市场收购 ATH,以进一步支持该策略,同时用于营运资金和一般企业用途。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10